AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
Clinical trial NCT03668340 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03668340
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2026-07-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.